NovaBridge Biosciences

NBPSEC EDGAR
Form 4, Insider transaction

Phillip Andrew Dennis, Chief Medical Officer

Share transactions

DateTransactionSecuritySharesPriceAmount
September 18, 2026
S Open-market sale
Common stock−8,209$0.71$5,828
September 17, 2026
M Option exercise
Common stock+23,695No costNo cost
Shares held directly after the transactions: 173,427.
Codes A, F and M are not open-market trades.

Official document

NovaBridge Biosciences, Form 4SEC EDGAR file no. 0002089237-26-000008
View document